Study of Paclitaxel eith GDC-0941 vs Paclicaxel with placebo in patients with locally recurrent or Metastatic Breast Cancer
-
Investigator: Michelle Melisko, MD
Sponsor: Genentech, Inc.
Location(s): United States
Description
This multicenter, randomized, single-blind, placebo-controlled, two arm study will evaluate the efficacy and safety of paclitaxel with GDC-0941 versus paclitaxe l with placebo in patients with locally recurrent or metastatic breast cancer.